Seer, Inc. SEER

FY2025 · ended Dec 31, 2025 · Revenue $16.58M, +17.0% YoY · Filed Mar 2, 2026

Seer, Inc. (SEER) files with the SEC under industry code 3826, Laboratory Analytical Instruments. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $16.6 million and a net loss of $73.6 million. Free cash flow was -$46.2 million. As of Jun 30, 2026 it held $209.5 million in cash and investments and $22.4 million in total debt.

Revenue (TTM)
$14.22M
-12.7% vs year-ago TTM
Net income (TTM)
$-67.96M
+17.6% vs year-ago TTM
Operating cash flow (TTM)
$-43.38M
+16.0% vs year-ago TTM
Free cash flow (TTM)
$-44.23M
+18.9% vs year-ago TTM
EPS
$-1.35
+9.4% vs prior year
Dividend per share (TTM)
$0.00
Shares outstanding
56.42M
Net cash
$187.09M
as of Jun 30, 2026
Operating margin
-498.2%
FY 2026

Company profile

Industry
Laboratory Analytical Instruments (SIC 3826)
Listed as
SEER (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Redwood City, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1726445
Former names
Seer Biosciences, Inc. (until Jan 4, 2018)

Other Laboratory Analytical Instruments companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$16.6M
$14.2M
$16.7M
$15.5M
$6.6M
Operating income
-$78.0M
-$100.1M
-$103.5M
-$97.2M
-$71.5M
Net income
-$73.6M
-$86.6M
-$86.3M
-$93.0M
-$71.2M
Diluted EPS
—
—
-$1.35
-$1.49
-$1.17
Operating cash flow
-$44.4M
-$46.1M
-$59.1M
-$60.8M
-$46.3M
Free cash flow
-$46.2M
-$49.7M
-$66.4M
-$71.0M
-$53.3M
Total assets
$296.1M
$366.6M
$436.3M
$487.9M
$539.1M
Total liabilities
$36.8M
$39.0M
$39.4M
$40.9M
$36.2M
Stockholders' equity
$259.3M
$327.6M
$396.9M
$447.0M
$502.9M
Cash and investments
$240.6M
$299.5M
$373.1M
$426.4M
$493.3M
Total debt
$23.7M
$26.0M
$28.3M
$29.9M
$23.3M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Other events
Oct 29, 2026 Oct 29, 2026
8-K Current report
Officer or director change
Sep 18, 2026 Sep 14, 2026
10-Q Quarterly report Aug 11, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 11, 2026 Aug 11, 2026
8-K Current report
Shareholder vote results
Jul 31, 2026 Jul 28, 2026
8-K Current report
Other events
Jul 31, 2026 Jul 28, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.